Acetylcholine receptors sensitive to the nematode-specific cholinergic agonist levamisole (L-AChRs), are hetero-pentameric ligand-gated ion channels that mediate fast excitatory neurotransmission at C. elegans neuromuscular junctions (NMJs). The cell biological mechanisms and genes involved in the assembly, trafficking and synaptic clustering of levamisole-sensitive AChR start to be well understood. However, its basic pharmacological properties remain largely unknown due to the lack of a reliable heterologous expression system. We have succeeded in getting robust expression of the L-AChR in Xenopus oocytes by using information derived from C. elegans genetics. In vivo, at least eight genes are necessary to produce L-AChR: five genes (
lev-1,
lev-8,
unc-29,
unc-38,
unc-63) encode AChR subunits and three genes encode proteins involved in intracellular trafficking and protein maturation (
ric-3,
unc-50,
unc-74). We have co-injected the corresponding cRNAs into Xenopus oocytes and observed robust expression of the L-AChR 2 to 3 days after injection. Strikingly, each of the eight genes is required for efficient L-AChR expression in Xenopus oocytes. Acetylcholine elicits currents in the microA range, with fast activation kinetics and almost no desensitization. Similarly, robust responses are obtained for levamisole, which behaves as a partial agonist. d-Tubocurarine, MLA and hexamethonium, classical antagonists of AChR, inhibit the currents. Acetylcholine and levamisole ECs calculated in dose-response experiments are 25 microM and 10 microM, respectively. Surprisingly, nicotine, the prototypic agonist of ionotropic acetylcholine receptor, does not activate the L-AChR, but rather acts as a strong antagonist. In the future, we will use this new expression system to examine the molecular basis for the unusual pharmacological properties of L-AChR. In addition, the system will be useful to study the function of the novel gene
molo-1 which acts as a positive allosteric modulator of L-AChR in vivo.